18.11.2022

A team of experts at Capgemini, in collaboration with University Hospital Bonn and Amazon Web Services, has developed an artificial intelligence (AI) model that will accelerate the speed of clinical trials aiming to establish new treatments for River Blindness, a neglected tropical disease which affects over 20 million people globally. Currently, the specialist work of clinical trials can only be carried out manually by a handful of global experts, so the winning model could save years of work and speed up the development of new treatments.

https://www.capgemini.com/news/client-stories/harnessing-the-power-of-ai-to-combat-river-blindness/

https://www.capgemini.com/news/inside-stories/code-for-a-cure/